INHIBITORS OF JNK

The invention relates to prodrugs of JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses prodrugs of JNK inhibitors, as described below in formula I: wherein m, n, p, q, Q, r, R1, R2, R3, X, X1, X2...

Full description

Saved in:
Bibliographic Details
Main Authors GOLDSTEIN DAVID MICHAEL, GONG LEYI, TREJO MARTIN TERESA ALEJANDRA, HOGG JOAN HEATHER, TIVITMAHAISOON PARCHAREE, PALMER WYLIE SOLANG, REUTER DEBORAH CAROL, WU SHAO YONG, DUNN JAMES PATRICK, JAHANGIR ALAM, HAN XIAOCHUN, ARZENO HUMBERTO BARTOLOME, SILVA TANIA
Format Patent
LanguageEnglish
Korean
Published 30.12.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to prodrugs of JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses prodrugs of JNK inhibitors, as described below in formula I: wherein m, n, p, q, Q, r, R1, R2, R3, X, X1, X2, X3, X4, X5, Y1, Y2, Z1 and Z2 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity. Disclosed are methods and formulations for inhibiting JNK and treating JNK-mediated disorders, and the like, with the compounds, and processes for making said compounds, and corresponding compositions, disclosed herein.
Bibliography:Application Number: KR20107025625